3/20/2023 4:08:49 PM
William Blair Reiterates Incyte Corporation (INCY) At Outperform
3/7/2023 6:31:47 AM
Caris Life Sciences, Incyte Enter Broad Precision Medicine Partnership To Advance Incyte's Oncology Pipeline
2/7/2023 7:07:23 AM
Incyte Q4 GAAP EPS $0.13; Non-GAAP EPS $0.62
12/5/2022 7:10:18 AM
Syndax Pharma, Incyte Publish Axatilimab Phase 1/2 Data In Patients With Chronic Graft-Versus-Host Disease
11/1/2022 7:09:06 AM
Incyte Q3 GAAP EPS $0.50; Non-GAAP EPS $0.60
8/26/2022 10:02:40 AM
Incyte : FDA Approves Pemazyre As Targeted Treatment For Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
8/2/2022 7:09:50 AM
Incyte Q2 GAAP EPS $0.72; Non-GAAP EPS $1.01